The biodistribution and imaging of a novel amyloid probe 131I-serum amyloid P-component in mice model of amyloidosis
Hai-liang WEI,Chun-li ZHANG,Rong-fu WANG,Jian-hua ZHANG,Ping YAN,Lei KANG,Feng-qin GUO
DOI: https://doi.org/10.3760/cma.j.issn.0253-9780.2011.06.014
2011-01-01
Abstract:Objective To validate 131 I-serum amyloid P-component (SAP) as a novel amyloid probe in mice bearing amyloidosis and evaluate its diagnostic value.Methods Standard SAP was labeled with 131I using Iodogen method.Amyloidotic mice model was established by subcutaneous injection of 0.5 ml 10％ Casein daily for 21 d,and the control group was injected with 0.5 ml saline.Both groups were injected with 7.4 MBq131 I-SAP through the tail veins and imaging was performed at 1,3,6,24,48 and 72 h post injection.In biodistribution study,30 amyloidotic mice model and 30 controls were injected with 555 kBq 131 I-SAP and were killed evenly at 1,3,6,24,48 and 72 h post injection.T test was used to analysis the data.Results The labeling efficiency of 131 I-SAP was 70.6％,and the radiochemical purity was ( 95.5 ±3.4) ％.There was significant tracer uptake by liver,spleen and kidney at 24 h in the test group and mild uptake by these organs in the control group.The uptake ratios of liver,spleen and kidney over blood in the test group were 2.201 ±0.301,2.139 ±0.223,4.797 ±0.615,vs 0.657 ±0.126,1.014 ±0.063,0.607 ±0.028 in the control group,respectively (t =10.747,11.626 and 15.135,all P ＜0.01).The uptake differences between the two groups were still statistically significant at 48 h ( t =15.128,4.558,16.960,all P ＜ 0.01 ).The uptake ratios of spleen over blood between the two groups were not significantly different at 72 h ( t =3.022,P ＞ 0.05 ),but the other two uptake ratios were both sigificantly different ( t =7.801,6.442,both P ＜ 0.01 ).Conclusions SAP can be reliably labeled with 131I.The labeled product 131 I-SAP can accumulate in amyloid laden tissues,thus rendering it a potential agent in the detection of amyloidosis.